Trial Profile
The Effect of Everolimus on Renal, Brain, Skin Lesions and Seizure of Tuberous Sclerosis Complex
Status:
Active, no longer recruiting
Phase of Trial:
Phase I
Latest Information Update: 18 Jun 2018
Price :
$35
*
At a glance
- Drugs Everolimus (Primary)
- Indications Tuberous sclerosis
- Focus Therapeutic Use
- 18 Jun 2018 New trial record